Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to estimate the effects of a palliative care consultation intervention among adults with advanced cancer delivered either as a remote (telemedicine) or face-to-face consultation, on changing symptom scores, quality of life, communication, participants' experiences, e-health literacy, emergency and unscheduled visits, adherence to treatment, retention rate, adherence rate, the level of satisfaction of patients and healthcare professionals.
This is a prospective, single-centre, randomized, with parallel assignment, controlled trial, with a 1:1 allocation across two treatment arms: telemedicine consultations versus face-to-face consultations.
All trial activities will be conducted through the Outpatient Clinic of OncoHelp Association located in Timisoara, Romania.
Participants in this study will be recruited from newly diagnosed cancer patients who have not received palliative care interventions prior to enrollment. They are referred to the Outpatient Clinic of the OncoHelp Association for oncological and palliative registration, consultations, and treatment.
After gaining informed consent, a baseline assessment will be collected, including screening feasibility for the telemedicine arm. The selected patients will be randomly allocated with a 1:1 ratio to receive either:
Telemedicine consultation ( Intervention Arm) Group A Face-to-Face consultation ( Control Arm) Group B The participants will receive three monthly consultation and unscheduled consultations as they need according to the study arm they had been allocated.
The participants will benefit from the following categories of interventions depending on their needs :
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Telemedicine consultations | Experimental | The experimental intervention will be delivered via Zoom and Video WhatsApp platforms via a secure internet connection. |
|
| Face-to-Face Consultations | Active Comparator | Patients randomised to the control arm will continue with face-to-face consultations according to the standard of care. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telemedicine Consultation | Other | Telemedicine intervention will be delivered via Zoom and Video WhatsApp platforms via a secure internet connection. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patients' Quality of Life . | To determine whether telemedicine palliative care consultations are equivalent to face-to-face palliative care consultations for improving patients' quality of life as measured by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire(EORTC-QLQ-C30). All of the scales range in score from 0 to 100. A high score for a functional scale represents a high/healthy level of functioning whereas a high score for a symptom scale or item represents a high level of symptomatology or problems. Patients' Quality of Life [ Time Frame:12 weeks] To determine whether telemedicine consultations palliative care is are equivalent to face-to-face palliative care consultations for improving patients' quality of life as measured by the EORTC-QLQ-C30 Questionnaire. | 12 weeks |
| Changes in symptom control . | Symptom management will be measured through the mean changes in distress score on the Integrated Palliative care Outcome Scale (IPOS). There are 10 questions scored on a scale of 1-4, which assess a patient's symptoms and needs with regards to physical, social, psychological and spiritual. Individual IPOS item scores of zero or one require less clinical attention than items that score three or four. | 12 weeks |
| Patients' satisfaction . | To assess the effect of the superiority of telemedicine versus face-to-face consultations about palliative care on patient satisfaction as measured by the 16-item measure of Patient Satisfaction Questionnaire(FAMCARE P 16 Questionnaire). This is a self-report scale assessing patient satisfaction with outpatient palliative oncology care, which is composed of 16 items rated from 1 (very dissatisfied) to 5 (very satisfied). Higher scores are related to higher satisfaction with the care received. | 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| eHealth Literacy . | Participants' ability to find and evaluate online health information will be measured using the eHealth Literacy Scale. The eHealth literacy scale is an eight-item scale used to asses self-reported capability of eHealth consumers to find, appraise, and use health related information from the internet to solve health problems . Scores are interpreted as follows: Predominantly Disagree: Scores range from 8 to 15.99; Mostly Disagree: Scores range from 16 to 23.99. Mostly Agree: Scores range from 24 to 31.99. Predominantly Agree: Scores range from 32 to 40. |
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of participants enrolled | The proportion of eligible and approached patients who consent to participate. | Baseline |
| Number of participants ineligible or refusing to participate . | Number of participants who are determined to be ineligible before the first visit. |
Inclusion Criteria:
Participant Inclusion Criteria
Caregiver Inclusion Criteria
Exclusion Criteria:
Participant Exclusion Criteria
Caregiver Exclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alexandra Kovacs, MD | Contact | 0040742041811 | aflavia.kovacs@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Alexandra Kovacs, MD | OncoHelp Association | Study Chair |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41550463 | Derived | Kovacs A, Payne S, Mosoiu D. Efficacy of telemedicine for cancer patients in outpatient palliative care setting: Protocol of a randomized, open-label, non-inferiority study. Palliat Care Soc Pract. 2026 Jan 13;20:26323524251408888. doi: 10.1177/26323524251408888. eCollection 2026. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Prospective, single-centre, randomized, with parallel assignment, controlled trial, with a 1:1 allocation across two treatment arms: telemedicine consultations versus face-to-face consultations
Not provided
Not provided
Not provided
Not provided
| Face-to-Face Consultation | Other | Face-to-Face consultation according to the standard of care. |
|
| Baseline and 12 weeks after baseline |
| Domain of intervention . | The interventions provided in this study will respect the principle of holistic care. Depending on the patient's needs, interventions will be provided in the physical, emotional, social, and spiritual domains during each scheduled or unscheduled visit. During each visit, the interventions granted and the domains - physical, emotional, social and spiritual - to which these interventions belong will be recorded. | 12 weeks |
| Number of patients satisfied with physician communication . | 14-item Communication Assessment Tool (CAT) will be used. The CAT specifically addresses patient satisfaction with key aspects of communication and interpersonal skills, and items are scored on a 1-5 scale where 1 = poor and 5 = excellent, and a higher score would indicate better communication skills. | 12 weeks |
| Patients' experiences . | Participants' experiences with the care will be measured using the Patient Reported Experience Measures Questionnaire (PREMs). Patients' experience is rated from poor (rated as 1) to excellent (rated as 5). Higher scores are related to higher satisfaction during consultation. | 12 weeks |
| Number of emergency room visit . | Monitoring patient interactions with the Emergency Room (ER) during the trial period. | 12 weeks |
| Number of unscheduled visits . | Monitoring the number of unscheduled visits. | 12 weeks |
| Adherence to intervention . | Intervention adherence will be estimated as the mean proportion of the scheduled consultations each participant completes . | 12 weeks |
| Changes in medication adherence . | Medication adherence will be measured using the Morisky Medication - Taking Adherence Scale (MMAS-4 Scale). The MMAS consists of four items, with a scoring scheme of "Yes" = 0 and "No" = 1. The items are summed to give a range of scores from 0 to 4 . | 12 weeks |
| Number of completed telemedicine scheduled visits . | Telemedicine will be feasible in this population if at least 80% complete the telemedicine visits. A visit will be considered successful if all measurements are recorded. | 12 weeks |
| Physicians ability to evaluate a patient through telemedicine . | Measured by the Provider Satisfaction with Telemedicine Questionnaire. This questionnaire will be completed by the interventionists after visit 3 . This survey included included 5 components: demographics, care settings, experience, motivation, and overall satisfaction. | 12 weeks |
| Baseline |
| Frequency of participant ineligibility reason | Potential study candidates who are ineligible will be recorded for reasons of ineligibility. | Baseline |
| Frequency of participant refusal reason | Potential study candidates who decide not to participate will be recorded for refusal reasons. | Baseline |
| Retention rate | The percentage of patients who remained in the study and did not drop out of their own accord. | 12 weeks |
| Completion rate | The percentage of patients who completed the study period. | 12 weeks |